Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jun 22, 2026
Why Is AeroVironment (AVAV) Stock Down -7.6% Today?

Why Is AeroVironment (AVAV) Stock Down -7.6% Today?

Key Takeaways

  • AeroVironment shares plunged approximately 7.6% in early trading on Monday, extending a brutal year-to-date decline that has already erased roughly one-third of the stock's value.
  • The primary catalyst was the revelation of an $89.4 million understatement in operational losses for the three and nine months ending January 31, 2026, tied to a goodwill impairment on the terminated SCAR contract.
  • The company also disclosed a material weakness in its financial reporting controls, raising serious concerns about internal oversight and the reliability of prior financial statements.
  • Multiple securities class action lawsuits continue to mount, with a lead plaintiff deadline of July 27, 2026, adding a persistent legal overhang to the stock.
  • Broader defense-sector weakness and lingering uncertainty around the SCAR program recompete are compounding the selling pressure.
  • Traders are now squarely focused on the company's fiscal fourth-quarter earnings report, expected after the market closes on June 29, for any signs of stabilization.

Opening Summary

AVAV, the Arlington, Virginia-based defense technology company known for its Switchblade loitering munitions, uncrewed aircraft systems, and counter-UAS platforms, saw its shares tumble sharply on Monday. The stock dropped approximately 7.6% in early trading after the company disclosed a significant understatement of prior operating losses. The sell-off reflects deepening investor anxiety over financial controls, the fallout from a lost $1.7 billion Space Force contract, and an increasingly complex legal landscape. The move lower punctuates a punishing stretch for AVAV, which has now fallen roughly 33% year-to-date and trades near its 52-week lows.

Restated Financials Reveal Deeper Losses

The immediate trigger for Monday's decline was the disclosure that AeroVironment had understated its operational loss by $89.4 million for the three and nine months ending January 31, 2026. The restatement, which translated to an additional $1.75 per share in basic and diluted losses for the three-month period, stemmed from a goodwill impairment charge linked to the now-terminated Satellite Communication Augmentation Resource (SCAR) contract with the U.S. Space Force. The company also acknowledged a material weakness in its internal controls over financial reporting, a red flag that calls into question the accuracy of prior disclosures and management's oversight of the accounting function. For a defense contractor whose business depends on trust and credibility with government customers, the control deficiency is particularly damaging.

SCAR Contract Fallout Continues to Reverberate

The SCAR program has been the single largest overhang on AVAV shares since January 2026, when the U.S. Space Force issued a stop-work order on the company's BADGER phased-array antenna delivery agreement. What management had once described as a "$1 billion franchise" and a "tremendous growth opportunity" unraveled in a series of corrective disclosures that ultimately revealed the contract had been terminated for convenience. The Space Force shifted to a multi-vendor acquisition strategy, forcing AeroVironment to recompete for work it had previously treated as secured backlog. The $151.3 million goodwill impairment recorded in the fiscal third quarter was a direct consequence of that termination, and Monday's restatement shows the financial damage was even deeper than initially reported.

Legal Overhang Intensifies

Compounding the fundamental concerns, AeroVironment faces a growing wave of securities class action lawsuits. Multiple law firms have filed complaints on behalf of investors who purchased shares between June 25, 2025 and March 10, 2026, alleging that the company and certain officers made materially misleading statements about the security and stability of the SCAR program. The lead plaintiff deadline of July 27, 2026 has triggered a fresh round of investor alerts and legal notices, keeping the litigation risk front and center. While securities class actions of this type typically take years to resolve, the reputational damage and potential financial exposure add another layer of uncertainty that is weighing heavily on the stock.

Market Context and Trading Activity

Monday's sell-off occurred against a backdrop of broader weakness in defense technology names. Peers such as KTOS and RCAT also traded lower, reflecting sector-wide pressure. Trading volume in AVAV was elevated relative to the daily average, indicating conviction behind the move. The stock has now broken below several key technical levels and remains firmly beneath both its 50-day and 200-day moving averages. Short interest has been climbing and now represents more than 12% of the available float, suggesting that bearish sentiment is deeply entrenched. With the shares hovering near the $156 level that marked the May 2026 trough, traders are watching closely to see whether that support floor can hold.

Trending AI Robots

In volatile market environments like the one currently facing defense stocks, traders often turn to data-driven tools to help navigate the turbulence. Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to identify opportunities across thousands of tickers. These bots vary by strategy, timeframe, and performance metrics, but only the strongest performers under current market conditions are featured in this dynamic section. Whether markets are trending or choppy, the platform provides traders with real-time signals and automated analysis to support more informed decision-making. Explore the Trending AI Robots page to see which strategies are currently leading the pack.

What Comes Next for AVAV

The next major catalyst for AVAV is the release of fiscal fourth-quarter and full-year 2026 results, scheduled for after the market closes on Monday, June 29. Analysts expect earnings of approximately $1.47 per share on revenue of roughly $557 million. Beyond the headline numbers, investors will be scrutinizing management's fiscal 2027 guidance, commentary on the SCAR recompete process, and any updates on the material weakness remediation plan. The company's investor day on July 8 in New York City could also serve as a platform to rebuild credibility, though the path to restoring confidence appears long. Key risks include further contract disruptions, adverse legal developments, and the possibility that the BlueHalo acquisition—completed in 2025 at a cost of $4.1 billion—fails to deliver the promised synergies and revenue acceleration. Until there is clarity on these fronts, the stock is likely to remain under pressure.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AVAV

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AVAV's Stochastic Oscillator remains in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for AVAV crossed bullishly above the 50-day moving average on August 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVAV advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 225 cases where AVAV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AVAV moved out of overbought territory on August 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AVAV as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AVAV turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

AVAV moved below its 50-day moving average on August 20, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVAV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AVAV broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AVAV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.850) is normal, around the industry mean (7.037). P/E Ratio (149.026) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.077). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (3.978) is also within normal values, averaging (20.174).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
AVAV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of unmanned aircraft and charging systems

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
241 18th Street South
Phone
+1 703 418-2828
Employees
3731
Web
https://www.avinc.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
Why Is AeroVironment (AVAV) Stock Down -7.6% Today?